cupure logo

Weight loss jabs do not slow Alzheimer's disease as hoped, causing firm's share prices to plummet

Novo Nordisk had hoped to repurpose semaglutide - the active ingredient in its Wegovy and Ozempic jabs - as a groundbreaking dementia treatment after seeing early encouraging signs.

Comments

Similar News

Breaking news